| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |